| Mean | Median | Minimum | Maximum | IQR |
---|---|---|---|---|---|
Health sector cost per service in US$ # | Â | Â | Â | Â | Â |
Microscopy | 1.89 | 1.87 | 1.61 | 2.21 | Â |
Rapid diagnostic test | 1.92 | 1.97 | 1.63 | 2.23 | Â |
Outpatient visit excl drugs | 0.47 | 0.43 | 0.37 | 0.64 | Â |
Artimisinin-based combination therapy (SP/AS), adult course | 1.14 | 1.14 | 1.10 | 1.19 | Â |
Artimisinin-based combination therapy (SP/AS), child course | 0.65 | 0.65 | 0.63 | 0.68 | Â |
Chloroquine, adult course | 0.14 | 0.14 | 0.13 | 0.14 | Â |
Chloroquine, child course | 0.06 | 0.06 | 0.06 | 0.07 | Â |
Sulphadoxine-pyrimethamine, adult course | 0.14 | 0.14 | 0.13 | 0.14 | Â |
Sulphadoxine-pyrimethamine, child course | 0.06 | 0.06 | 0.06 | 0.07 | Â |
Antibiotics, adult course | 0.14 | 0.14 | 0.13 | 0.14 | Â |
Antibiotics, child course | 0.14 | 0.14 | 0.13 | 0.14 | Â |
Diagnostics training cost in US$ for health personnel per patient enrolled | Â | Â | Â | Â | |
Microscopy | 0.10 | Â | Â | Â | Â |
Rapid diagnostic test | 0.03 | Â | Â | Â | Â |
Household cost in US$ (over a period of 28Â days from the first visit) & | Â | Â | Â | Â | |
Out-of-pocket expenditure, patient appropriately treated | 3.77 | 0.00 | 0.00 | 129.15 | (0.00; 0.00) |
Out-of-pocket expenditure, patient inappropriately treated | 6.92 | 0.00 | 0.00 | 116.11 | (0.00; 1.64) |
Opportunity cost of time lost, patient appropriately treated | 1.71 | 0.00 | 0.00 | 25.93 | (0.00; 2.47) |
Opportunity cost of time lost, caregiver of patient appropriately treated | 0.65 | 0.00 | 0.00 | 16.05 | (0.00; 0.00) |
Opportunity cost of time lost, patient inappropriately treated | 2.67 | 0.00 | 0.00 | 19.75 | (0.00; 3.70) |
Opportunity cost of time lost, caregiver of patient inappropriately treated | 0.98 | 0.00 | 0.00 | 9.88 | (0.00; 1.23) |